Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
It hasn't been the best quarter for Universal Health Services, Inc. (NYSE:UHS) shareholders, since the share price has fallen 13% in that time. But over three years, the returns would have left most investors smiling In the last three years the share price is up, 63%: better than the market.
对于Universal Health Services,Inc.(NYSE:UHS)股东来说,这并不是最好的一个季度,因为股价在此期间下跌了13%。 但在过去的三年里,回报率可能会让大多数投资者微笑。在过去的三年里,股价上涨了63%:优于市场。
Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.
让我们长期看一下潜在的基本面,看看它们是否与股东回报一致。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
虽然一些人仍然在教授高效市场假说,但已经证明市场是过度反应的动态系统,投资者不总是理性的。一种有缺陷但合理的评估公司情绪变化的方法是比较每股收益 (EPS) 与股价。
During three years of share price growth, Universal Health Services achieved compound earnings per share growth of 7.3% per year. This EPS growth is lower than the 18% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. That's not necessarily surprising considering the three-year track record of earnings growth.
在股价增长的三年期间,Universal Health Services实现了每股收益的复合增长率为7.3%。 这种每股收益增长低于股价平均年增长率的18%。 这表明,随着业务在过去几年的进展,它赢得了市场参与者的信任。 考虑到过去三年收益增长的记录,这并不奇怪。
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
下图显示了EPS随时间的变化情况(如果您单击该图像,则可以查看更多详细信息)。
We know that Universal Health Services has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Universal Health Services will grow revenue in the future.
我们知道universal health services最近改善了其底线,但它的营业收入会增长吗? 检查分析师是否认为universal health services未来会增长营业收入。
What About Dividends?
关于分红派息的问题
It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Universal Health Services, it has a TSR of 65% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!
考虑任何给定股票的总股东回报以及股价回报是很重要的。而股价回报仅反映了股价的变化,TSR则包括了股息的价值(假设它们已经再投资)以及任何折扣后的资本筹集或分拆的好处。因此,对于支付丰厚股息的公司,TSR通常比股价回报高得多。就universal health services而言,过去3年的TSR为65%。这超过了我们之前提到的股价回报。这在很大程度上是其股息支付的结果!
A Different Perspective
另一种看法
We're pleased to report that Universal Health Services shareholders have received a total shareholder return of 47% over one year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 8% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Universal Health Services has 1 warning sign we think you should be aware of.
我们很高兴地报告,universal health services股东在一年内获得了总股东回报率达47%。并且这包括了股息。由于一年的TSR优于五年的TSR(后者为每年8%),似乎股票的表现近来有所改喹。鉴于股价势头依然强劲,值得更加仔细地研究这支股票,以免错失机会。我发现长期来看股价作为业务表现的替代指标非常有趣。但要真正获得见解,我们也需要考虑其他信息。例如承担风险 - universal health services有1个警告标志,我们认为您应该注意。
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
如果您和我一样,那么您一定不想错过这份免费的被内部人员买入的低估小盘股清单。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文所引述的市场回报反映了目前在美国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。